Skip to main content

Find Clinical Trials

Home
Conditions
Plaque, Amyloid

Clinical trial condition

Plaque, Amyloid

Explore clinical trials studying Plaque, Amyloid. Study availability and eligibility vary by location and protocol.

214 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Plaque, Amyloid trial results

Completed

Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens

NCT01406938

Conditions: Dermatitis, Moderate to Severe Plaque-type Psoriasis, Pathological Conditions, Anatomical, +6 more
Locations: Novartis Investigative Site Fresno, California, United States

Novartis Investigative Site Pasadena, California, United States

Novartis Investigative Site Sacramento, California, United States

Novartis Investigative Site San Francisco, California, United States

View all 131 locations

View Trial Details

Completed

Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis

NCT01412944

Conditions: Dermatitis, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, +6 more
Locations: Novartis Investigative Site Jacksonville, Florida, United States

Novartis Investigative Site West Palm Beach, Florida, United States

Novartis Investigative Site Boston, Massachusetts, United States

Novartis Investigative Site St Louis, Missouri, United States

View all 27 locations

View Trial Details

Completed

Multiple-loading Dose Regimen Study in Patients With Chronic Plaque-type Psoriasis

NCT00805480

Conditions: Chronic Plaque Psoriasis, Dermatitis, Pathological Conditions, Anatomical, +6 more
Locations: Not specified

View Trial Details

Completed

BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population

NCT00738725

Conditions: Atherosclerotic Disease, Brain Diseases, Cardiovascular Diseases, +11 more
Locations: North Ridge Medical Center Oakland Park, Florida, United States

Forest Med-Surg Center Justice, Illinois, United States

View Trial Details

Completed

Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's Disease

NCT02243982

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +18 more
Locations: Hospital Clinic Barcelona, Spain

View Trial Details

Completed

Alzheimer's Disease Neuroimaging Initiative Grand Opportunity

NCT01078636

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +13 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Banner Alzheimer's Institute Phoenix, Arizona, United States

Banner Sun Health Research Institute Sun City, Arizona, United States

University of California, Irvine Irvine, California, United States

View all 55 locations

View Trial Details

Completed

Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers

NCT00750282

Conditions: Alzheimer Disease, Amyloid Beta-Protein, Brain Diseases, +10 more
Locations: Sun City, Arizona, United States

Stanford, California, United States

New Haven, Connecticut, United States

New York, United States

View all 23 locations

View Trial Details

Completed

Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients

NCT01138111

Conditions: Alzheimer Disease, Amyloid Beta-Protein, Brain Diseases, +10 more
Locations: Heidelberg, Victoria, Australia

View Trial Details

Completed

Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis

NCT02133807

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +14 more
Locations: Russian Cardiology Research and Production Center Moscow, Russia

View Trial Details

Completed

Phase II Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid.

NCT00928304

Conditions: Abnormalities, Multiple, Amyloid Beta-Protein, Chromosome Disorders, +11 more
Locations: Sun City, Arizona, United States

New Haven, Connecticut, United States

View Trial Details